New adrenergic blocking agent Visken (LB-46) in the treatment of chronic coronary disease
Musial, W.; Tracz, W.; Krzemińska-Pakula, M.
Polski Tygodnik Lekarski 26(22): 834-836
1971
ISSN/ISBN: 0032-3756 PMID: 4397439 Document Number: 42971
Document emailed within 1 workday
Related Documents
Sonkodi, S.; Pap, A.; Varró, V. 1976: Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes Therapia Hungarica 24(2): 60-62Shen, J.Q. 1981: Atenolol, a new beta-adrenergic blocking agent, in treatment of hypertension: therapeutic effect and hemodynamic changes Zhonghua Xin Xue Guan Bing Za Zhi 9(2): 94-98
Calvagno, M. 1982: Usefulness of an alpha-adrenergic blocking agent (nicergoline) in the treatment of diabetic angiopathy of lower limbs Il Farmaco; Edizione Pratica 37(6): 200-205
Kitamura, S. 1980: The treatment of asthmatic patients using an alpha-adrenergic receptor blocking agent, co-dergocrine mesylate ('Hydergine') Pharmatherapeutica 2(5): 330-336
Metelitsa, V.I.; Filatova, N.P. 1990: Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study) Kardiologiia 30(5): 8-14
Gupta, S.; Ternberg, J.L.; Weldon, V.V.; Pagliara, A.S. 1973: Alpha-adrenergic blocking agent in childhood pheochromocytoma Surgery 74(4): 545-550
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147
Baïsset, A.; Dang-Tran, L.; Montastruc, P. 1971: Effect of an adrenergic beta-blocking agent on adrenaline-induced hyperglycemia in hypophysectomized dogs Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(11): 2209-2214
Miki, H. 1983: Effect of befunolol ophthalmic solution, alpha, beta-adrenergic blocking agent, on secondary glaucoma Nippon Ganka Gakkai Zasshi 87(1): 1-13
Hara, Y.; Sato, E.; Miyagishi, A.; Aono, S.; Nakatani, H. 1979: Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 75(7): 707-720
Adamska-Dyniewska, H. 1973: Changes in effort tolerance in patients with coronary arterial disease following administration of 4 beta-adrenolytic agents (propranolol, visken, oxyprenolol and practolol) Wiadomosci Lekarskie 26(13): 1201-1205
Goldstein, M.; Vincent, J.L.; D'Hollander, A.; Kahn, R.J.; De Smet, J.M.; Le Clerc, J.L. 1989: Absence of cardio-depressant effects of CGP 17582 B, a new beta-blocking agent, in patients after coronary surgery Acta Cardiologica 44(3): 229-234
Santini, P.; Ceccanti, M.; De Lorenzo, A.; Pisculli, M.; Di Giovanni, M.G.; Cavaleri, G.; Attilia, M.L.; Berbellini, A. 1986: Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism International Journal of Clinical Pharmacology Research 6(1): 73-76
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Yamamoto, N.; Nomura, M.; Okubo, K.; Maeda, K.; Goto, T. 1999: Pharmacologic characterization of FR172516: a new combined calcium channel-blocking and beta-adrenoceptor-blocking agent Journal of Cardiovascular Pharmacology 33(4): 587-594
Gettes, L.S. 1970: Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias Cardiovascular Clinics 2(2): 211-237
Asano, M.; Uchida, W.; Shibasaki, K.; Terai, M.; Inagaki, O.; Takenaka, T.; Matsumoto, Y.; Fujikura, T. 1990: Pharmacological profiles of YM-16151-1 and its optical isomers: a novel calcium entry blocking and selective beta-1 adrenoceptor blocking agent Journal of Pharmacology and Experimental Therapeutics 254(1): 204-211
Simon, B.; Bergemann, W.; Bouzo, H.; Hüttemann, W.; Hotz, F.; Müller, P.; Rösch, W. 1991: Prokinetic drug treatment (cisapride) is as effective as H2-blocking agent (ranitidine) in the treatment of gastric ulcer Hepato-Gastroenterology 38(Suppl 1): 41-45
Batlle, F.; Carreño, C.A.; Guetta, N.J.; Vassolo, E.; Bertolasi, C.A. 1970: Treatment of cardiac arrhythmias using a beta adrenergic receptor blocking drug Prensa Medica Argentina 57(38): 1801-1808
Lydtin, H. 1975: The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension Die Medizinische Welt 6(35): 1487-1492